Biocytogen Launches RenBiologics, A Sub-Brand Focused on Out-Licensing…
뉴스와이어신상품
0
60
0
01.25 15:10
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) today announced the launch of a new sub-brand, RenBiologics™, to represent the company’s antibody discovery business division. RenBiologics business will cover out-licensing/co-development of the company’s extensive library of fully human antibodies, as well as licensing of RenMice®, the company’s fully human antibody/TCR discovery platforms. The RenBiologics logo features an antibody with human-centric desig...